DexCom, Inc. DXCM
86.62
(0.85)
(0.97%)
as of 25 Sep
- Market cap
- $33.0B
- P/E
- 33.4×
Follow DXCM
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
DexCom, Inc. (DXCM) Free cash flow
DexCom, Inc.'s free cash flow for fiscal 2025 was $1.1B, up 70.8% from $630.7M in fiscal 2024. Over the twelve months to 30 June 2026 it was $1.4B. Over the past ten years it has ranged from $500.0K (fiscal 2016) to $2.7B (fiscal 2021); the current reading is higher than 91% of that period. Free cash flow has risen for 3 consecutive fiscal years. DexCom, Inc. ranks 9th of 149 Medical Devices companies by free cash flow.
Free cash flow, annual
Annual
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $1.1B | 70.79% |
| FY2024 | $630.7M | 23.21% |
| FY2023 | $511.9M | 68.00% |
| FY2022 | $304.7M | (88.80%) |
| FY2021 | $2.7B | 883.22% |
| FY2020 | $276.6M | 105.65% |
| FY2019 | $134.5M | 139.75% |
| FY2018 | $56.1M | 115.77% |
| FY2017 | $26.0M | 5,100.00% |
| FY2016 | $500.0K | (96.82%) |
Quarterly
| Period | Free cash flow | Change |
|---|---|---|
| Jun 2026 | $184.5M | (58.91%) |
| Mar 2026 | $449.0M | 133.73% |
| Dec 2025 | $192.1M | (66.85%) |
| Sep 2025 | $579.4M | 177.36% |
| 42 more quarters | Free account |
Against its own ten years
Low $500.0K
High $2.7B
Ten-year median
$276.6M
Current reading's percentile
91
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| BSX Boston Scientific Corporation compare | $3.6B |
| SNN Smith & Nephew SNATS, Inc. compare | $2.0B |
| PHG Koninklijke Philips N.V. compare | $1.8B |
| GEHC GE HealthCare Technologies Inc. compare | $1.6B |
| EW Edwards Lifesciences Corporation compare | $1.4B |
| DXCM DexCom, Inc. | $1.4B |
| ZBH Zimmer Biomet Holdings, Inc. compare | $1.0B |
| STE STERIS plc compare | $936.0M |
| PEN Penumbra, Inc. compare | $215.9M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on DXCM
- Revenue
- Net income
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement